- Home
- JFR vs SIBN Comparison
JFR vs SIBN Comparison
Compare JFR & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFR | SIBN |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2004 | 2018 |
Fundamental Metrics
Financial Performance| Metric | JFR | SIBN |
|---|---|---|
| Price | $7.24 | $21.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $25.44 |
| AVG Volume (30 Days) | ★ 904.7K | 544.8K |
| Earning Date | 01-01-0001 | 11-02-2026 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $15.53 |
| Revenue Next Year | N/A | $15.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $7.09 | $11.48 |
| 52 Week High | $8.00 | $22.95 |
Technical Indicators
Market Signals| Indicator | JFR | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 58.84 |
| Support Level | $7.23 | $16.34 |
| Resistance Level | $7.64 | N/A |
| Average True Range (ATR) | 0.09 | 0.78 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 44.55 | 54.79 |
Price Performance
Historical ComparisonAbout JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.